Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome

BACKGROUND: The phosphatidylinositol 3-kinase delta isoform (PI3Kδ) belongs to an intracellular lipid kinase family that regulate lymphocyte metabolism, survival, proliferation, apoptosis and migration and has been successfully targeted in B-cell malignancies. Primary Sjögren’s syndrome (pSS) is a c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Rheum Dis
Main Authors: Nayar, Saba, Campos, Joana, Smith, Charlotte G, Iannizzotto, Valentina, Gardner, David H, Colafrancesco, Serena, Pipi, Elena, Kollert, Florian, Hunter, Kelly J, Brewer, Charlotte, Buckley, Christopher Dominic, Bowman, Simon J, Priori, Roberta, Valesini, Guido, Juarez, Maria, Fahy, William A, Fisher, Benjamin A, Payne, Andrew, Allen, Rodger A, Barone, Francesca
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Sjögren's Syndrome
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352416/
https://ncbi.nlm.nih.gov/pubmed/30472652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2017-212619
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares